Home/Senhwa Biosciences/Tai-Sen Soong
TS

Tai-Sen Soong

Founder, Chairman & CEO

Senhwa Biosciences

Therapeutic Areas

Senhwa Biosciences Pipeline

DrugIndicationPhase
Silmitasertib (CX-4945)CholangiocarcinomaPhase II
Pidnarulex (CX-5461)Solid Tumors with HRDPhase I